NO885172L - Nye topiske metronidazolpreparater og terapeutiske anvendelser derav. - Google Patents

Nye topiske metronidazolpreparater og terapeutiske anvendelser derav.

Info

Publication number
NO885172L
NO885172L NO88885172A NO885172A NO885172L NO 885172 L NO885172 L NO 885172L NO 88885172 A NO88885172 A NO 88885172A NO 885172 A NO885172 A NO 885172A NO 885172 L NO885172 L NO 885172L
Authority
NO
Norway
Prior art keywords
preparations
therapeutic applications
formulations
new topical
drug
Prior art date
Application number
NO88885172A
Other languages
English (en)
Other versions
NO175883C (no
NO175883B (no
NO885172D0 (no
Inventor
Robert John Borgman
Original Assignee
Curatek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22202320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO885172(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Curatek Pharmaceuticals filed Critical Curatek Pharmaceuticals
Publication of NO885172D0 publication Critical patent/NO885172D0/no
Publication of NO885172L publication Critical patent/NO885172L/no
Publication of NO175883B publication Critical patent/NO175883B/no
Publication of NO175883C publication Critical patent/NO175883C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Cosmetics (AREA)
NO885172A 1987-03-20 1988-11-18 Fremgangsmåte for fremstilling av et preparat i vandig gelform for topisk anbringelse NO175883C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/000584 WO1988006888A1 (en) 1987-03-20 1987-03-20 Novel topical metronidazole formulations and therapeutic uses thereof

Publications (4)

Publication Number Publication Date
NO885172D0 NO885172D0 (no) 1988-11-18
NO885172L true NO885172L (no) 1988-11-18
NO175883B NO175883B (no) 1994-09-19
NO175883C NO175883C (no) 1994-12-28

Family

ID=22202320

Family Applications (1)

Application Number Title Priority Date Filing Date
NO885172A NO175883C (no) 1987-03-20 1988-11-18 Fremgangsmåte for fremstilling av et preparat i vandig gelform for topisk anbringelse

Country Status (10)

Country Link
EP (1) EP0305380B1 (no)
JP (1) JPH0825878B2 (no)
KR (1) KR950003919B1 (no)
AT (1) ATE67667T1 (no)
AU (1) AU610495B2 (no)
DE (1) DE3773383D1 (no)
DK (1) DK173844B1 (no)
FI (1) FI88582C (no)
NO (1) NO175883C (no)
WO (1) WO1988006888A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
US4859694A (en) * 1988-02-10 1989-08-22 Pavlich Frederick M Method for treating hoof thrush and hoof rot
GB8910076D0 (en) † 1989-05-03 1989-06-21 Thackray C F Ltd Sterilisable lubricant
SE506509C2 (sv) * 1992-04-14 1997-12-22 Bioglan Ab Användning av imidazoler för framställning av en farmaceutisk formulering för behandling av inflammatoriska och/eller infektiösa hudsjukdomar
FR2722098B1 (fr) * 1994-07-06 1996-08-23 Cird Galderma Nouveaux medicaments a base de metro-nidazole ou d'un melange synergetique de metronidazole et de clindamycine
GB9415290D0 (en) * 1994-07-28 1994-09-21 Zeneca Ltd Gel formation
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
US6468989B1 (en) * 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
US6387383B1 (en) * 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
FR2882552B1 (fr) * 2005-02-25 2008-12-26 Galderma Sa Gel aqueux de haute stabilite a base de metronidazole et procedes pour leur preparation
CA2791882C (en) 2010-03-12 2018-04-10 Monsanto Technology Llc Agrochemical gel compositions
CA3054236A1 (en) 2011-06-28 2013-01-03 Chemo Research Sl High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis
EP3013368A1 (en) 2013-06-25 2016-05-04 Mission Pharmacal Company Novel formulations for the treatment of vaginal disorders
US10660838B2 (en) 2017-06-23 2020-05-26 The Procter & Gamble Company Composition and method for improving the appearance of skin
US11622963B2 (en) 2018-07-03 2023-04-11 The Procter & Gamble Company Method of treating a skin condition
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
EP4157206A1 (en) 2020-06-01 2023-04-05 The Procter & Gamble Company Method of improving penetration of a vitamin b3 compound into skin
JPWO2022269665A1 (no) * 2021-06-21 2022-12-29
CN115350144A (zh) * 2022-07-28 2022-11-18 苏州弘森药业股份有限公司 一种甲硝唑水凝胶及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883661A (en) * 1971-11-09 1975-05-13 Syntex Inc Acne treatment
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment

Also Published As

Publication number Publication date
EP0305380A4 (en) 1989-06-26
FI885377A (fi) 1988-11-18
JPH0825878B2 (ja) 1996-03-13
DE3773383D1 (de) 1991-10-31
FI885377A0 (fi) 1988-11-18
WO1988006888A1 (en) 1988-09-22
AU610495B2 (en) 1991-05-23
FI88582B (fi) 1993-02-26
FI88582C (fi) 1993-06-10
KR950003919B1 (ko) 1995-04-20
DK173844B1 (da) 2001-12-10
EP0305380B1 (en) 1991-09-25
NO175883C (no) 1994-12-28
NO175883B (no) 1994-09-19
NO885172D0 (no) 1988-11-18
JPH01503061A (ja) 1989-10-19
AU7233787A (en) 1988-10-10
EP0305380A1 (en) 1989-03-08
ATE67667T1 (de) 1991-10-15
DK645488A (da) 1989-01-19
KR890701113A (ko) 1989-12-19
DK645488D0 (da) 1988-11-18

Similar Documents

Publication Publication Date Title
NO885172D0 (no) Nye topiske metronidazolpreparater og terapeutiske anvendelser derav.
DE68914365D1 (de) Topische metronidazol-formulationen und deren verwendung als arzneimittel.
DE3687341D1 (de) Hautwirksame pharmaka mit liposomen als wirkstofftraeger.
HUP9801234A2 (hu) Nitroglicerint tartalmazó, vizes alapú, helyileg alkalmazható krém, eljárás előállítására és alkalmazása
DK165440C (da) Farmaceutiske praeparater til topisk anvendelse indeholdende propylenglycol og/eller polyethylenglycol og urinstof som aktive hovedbestanddele
KR890007736A (ko) 11,28-디옥사-4-아자트리시클로[22.3.1.0^4·9]옥타코스-18-엔 유도체 및 이들을 함유한 약학적 조성물의 사용방법
NO883229L (no) Nye benzimidazolderivater, fremgangsmaate for deres fremstilling og farmasoeytisk preparat inneholdende slike derivater.
KR930012013A (ko) 건선과 과민성 피부염 치료에 국소적으로 사용되는 제약학적 성분물
FI862609A (fi) Akne motverkande produkt.
DK0700898T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme, til behandling af dermatoser.
ES2033021T3 (es) Agente con efecto destructivo a tumores malignos, procedimiento para su obtencion y preparacion para la aplicacion en la terapia de enfermos de cancer.
DK522186D0 (da) Melatoninmaterialer og deres anvendelser
ATE98868T1 (de) Topisch kosmetisch anzuwendende depolymerisierte nukleinsaeuren enthaltende arzneizubereitungen.
FI913100A0 (fi) Farmaceutiska preparat.
DE3762018D1 (de) Abwaschbare topische zubereitung zur therapie der psoriasis.
DK0700897T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme
EP0274104A3 (de) 13-cis-Retinsäure zur Verwendung in Präparaten gegen alternde Haut
IE45054L (en) Veterinary composition
US4915973A (en) Method for treating skin diseases
BR0315195A (pt) Composições farmacêuticas e usos das composições
FI861329A (fi) Anvaendning av 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat.
US6214889B1 (en) Topical application of formate for relief of adverse skin condition for humans
KR880003621A (ko) 의약 제제물
KR920700624A (ko) 피부도포용 수용성 비타민 a제제
ATE86611T1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.